FBONX | PGEMX | FBONX / PGEMX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 4 years | 30 years | - |
Gain YTD | 14.251 | 15.460 | 92% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 236B | 2.04B | 11,591% |
Annual Yield % from dividends | 2.50 | 0.70 | 359% |
Returns for 1 year | 24.74 | 26.15 | 95% |
Returns for 3 years | 17.33 | 9.08 | 191% |
Returns for 5 years | N/A | 31.42 | - |
Returns for 10 years | N/A | 71.39 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
BMCRX | 26.25 | N/A | N/A |
BlackRock Advantage Large Cap Gr R | |||
MAAWX | 10.07 | N/A | N/A |
Morgan Stanley US Focus Real Estate I | |||
VILSX | 40.23 | -0.03 | -0.07% |
Value Line Select Growth Institutional | |||
FBIOX | 21.71 | -0.09 | -0.41% |
Fidelity Select Biotechnology | |||
ETMGX | 32.49 | -0.35 | -1.07% |
Eaton Vance Tx-Mgd Small-Cap A |